Please login to the form below

Not currently logged in
Email:
Password:

Zosano appoints Chris Krueger as chief business officer

He joins from Ardea Biosciences

Chris Kruger has joined Zosano Pharma as chief business officer.

He joins the US-based biopharma from Ardea Biosciences, where he served as senior VP and chief business officer.

During his time at Ardea, Krueger completed a $407m global partnership with Bayer HealthCare.

In his new role, he will be responsible for business development, legal, and investor relations activities of Zosano as it prepares to expand its efforts in developing drug's utilising its novel drug delivery system.

Additional previous roles Krueger has held include senior executive positions at Protemix, Xencor, X–Ceptor Therapeutics and Aurora Biosciences.

His experience includes a broad range of transactions, including licensing, strategic alliances, mergers and acquisitions and equity and debt financings.

"It's exciting for me to join the Zosano team as the company enters its next stage of corporate growth," said Krueger.

"With its novel transdermal drug delivery system, Zosano is poised to develop therapeutic products through its own efforts and through strategic collaborations."

12th April 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics